ARTICLE SUMMARY:
RainDance’s platform of ultra-sensitive liquid biopsy genomic tools represents a fundamental breakthrough in detection and monitoring of complex diseases.
Roopom Banerjee was head of the life science tools and diagnostics practice at investment banking firm Leerink, raising over $1 billion and closing nearly 30 deals in three years, when the board of RainDance Technologies Inc. invited him in 2010 to lead their company.
